Medidata NEXT NYC 2019 Delivers Roadmap for Future Innovation in Clinical Research
NEW YORK--(BUSINESS WIRE)--Nov 13, 2019--
Medidata, a global leader in creating end-to-end solutions that support the entire clinical trial process, and part of Dassault Systèmes, concluded its most successful NEXT NYC event to date. The two-day conference in New York City featured sessions essential to accelerating value, minimizing risk, and optimizing outcomes in clinical research and development:
“We live in an age where healthcare is increasingly transformed by digital technologies,” said Glen de Vries, co-CEO and co-founder, Medidata. “This year’s Medidata NEXT NYC took us further down the path to explore how we, as an industry, can fulfill the promise of ensuring the right therapy gets to the right patient at the right time.”
The conference also served as an opportunity to discuss the customer and technological benefits of Medidata becoming part of Dassault Systèmes. Bernard Charlès, Vice Chairman and CEO, Dassault Systèmes remarked: “We are so pleased to welcome Medidata to our family. Together, we will elevate the collaborative process, connect virtual with real-world data, and invent the future of life sciences.”
Medidata NEXT NYC also hosted a one-day hackathon to inspire innovation around patient-centric clinical trials. Themed Real Patients, Virtual Trials, the “MediHack” inspired participants to create novel mobile applications with the Medidata AppConnect software kit with the goal of increasing virtual participation and patient recruitment rates in clinical trials.
The winner of the competition was a team from Memorial Sloan Kettering Cancer Center and Medidata for the “Trial Companion.” They conceived a mobile-friendly app to serve as a resource hub for patients, including the trial informed consent form, pop-ups with information based on their journey along the clinical trial, an AI-driven Q&A chatbox, and an ability to view relevant images and videos. Trial Companion would also integrate with popular home virtual assistants and incorporate translation services.
In appreciation of its industry relationships, the company announced the winners of its fourth annual Medidata Customer Awards. Six companies were recognized for their innovative approaches to addressing global patient needs and were selected for their achievements in four categories:
“We are proud to recognize the extraordinary, meaningful work our customers and partners do every day to advance drug research and improve the lives of patients around the world,” said Tarek Sherif, co-CEO and co-founder, Medidata. “Congratulations to all of this year’s award winners.”
Medidata NEXT will travel to Paris to open its 2020 season on March 31.
About Medidata NEXT
Medidata NEXT is the largest annual event series of its kind, and attracts over 3,000 leaders in drug and device development, clinical operations, data management, biostatistics, and digital medicine innovation industries. These professionals gather for networking and learning across six Medidata NEXT conferences in Basel, London, New York, Seoul, Shanghai and Tokyo.
Medidata is The Operating System for Life Sciences TM and precision medicine. Medidata helps pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access Medidata’s intelligent platform for clinical, commercial, and real-world data insights to create hope for millions of patients. Headquartered in New York City, Medidata has 16 locations around the world and is part of Dassault Systèmes (Euronext Paris: #13065, DSY.PA). Discover more at www.medidata.com, and follow us @Medidata.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191113005951/en/
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SOFTWARE RESEARCH MOBILE/WIRELESS GENERAL HEALTH INTERNET DATA MANAGEMENT TECHNOLOGY CLINICAL TRIALS SCIENCE OTHER TECHNOLOGY OTHER SCIENCE HEALTH
Copyright Business Wire 2019.
PUB: 11/13/2019 05:30 PM/DISC: 11/13/2019 05:30 PM